|
Our core platform
technologies are employed in the following business areas to
help partners effectively and efficiently meet their protein
production needs:
Vaccines
Transient gene expression provide a particularly effective
modality for developing vaccines used in the prevention and
treatment of diseases, including applications for anti-bioterrorism.
Protein
Therapeutics
Molecular farming offers a safer and less expensive means of
producing monoclonal antibodies (Mabs) while eliminating the
risk of contamination by animal pathogens, with low investment
scale-up.
Industrial
Enzymes
Molecular farming stimulates higher yield and significantly
reduces the costs associated with industrial biocatalysis;
while directed evolution allows improvement of enzyme
function.
Ag Biotech
Transient gene expression helps define the function of new
genes and can be used to alter the metabolism of plants for
the production of desired metabolites.
|
